Results from Phase II/III Trial Bring Hope for FDA Approval for New Niemann-Pick Disease Type C Treatment

Niemann-Pick Disease is a genetic lysosomal storage disease. Lipids accumulate in the lysosomes of cells, causing debilitating symptoms. There are three forms of the disease- A, B, and C. Each…

Continue Reading Results from Phase II/III Trial Bring Hope for FDA Approval for New Niemann-Pick Disease Type C Treatment

Yeast May be the Key to Uncovering Treatments for Homocystinuria and Other Metabolic Conditions

There is a great unmet medical need for patients living with metabolic disorders. There are few approved treatments for these conditions and many are fatal. These diseases include phenylketonuria, homocystinuria, tyrosinemia, and maple syrup…

Continue Reading Yeast May be the Key to Uncovering Treatments for Homocystinuria and Other Metabolic Conditions

New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections

Non-tuberculous mycobacterial (NTM) infections are caused by bacteria found in the environment. In healthy individuals, these bacteria normally cause no harm. However, for those who have a compromised immune system or who…

Continue Reading New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections
Xenon Issues Updates on Two of Its Investigational Drug Candidates
Skitterphoto / Pixabay

Xenon Issues Updates on Two of Its Investigational Drug Candidates

According to a story from globenewswire.com, the biopharmaceutical company Xenon Pharmaceuticals, Inc., recently announced the latest updates on the progress of two of its experimental products. The first is called…

Continue Reading Xenon Issues Updates on Two of Its Investigational Drug Candidates
Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
source: pixabay.com

Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit

Notable Labs Notable Labs was created after founder, Matt De Silva, felt he was left in a helpless point, following a year of research on treatment options for his father's Glioblastoma…

Continue Reading Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial
qimono / Pixabay

Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial

According to a story from statnews.com, the biotechnology company Alexion Pharmaceuticals recently announced that its product Ultomiris, which was recently approved as a treatment for paroxysmal nocturnal hemoglobinuria, was also…

Continue Reading Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial

Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019

Epidermolysis Bullosa Epidermolysis Bullosa (EB) refers to a group of rare conditions which are characterized by fragile skin. Basically, the disease is caused by separation between the layers of the skin.…

Continue Reading Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019
Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients
source: pixabay.com

Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients

The most common treatment for someone who is discovered to have early stage kidney cancer is surgery. The patient's tumors and a part of their kidneys are removed through a…

Continue Reading Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients
Cancer Rates Overall Have Been Dropping But It’s Not All Good News, Report Shows
Source: Pixabay

Cancer Rates Overall Have Been Dropping But It’s Not All Good News, Report Shows

The State of Cancer in the United States A recent report posted by the American Cancer Society has indicated that cancer rates in the United States have been continuously falling over…

Continue Reading Cancer Rates Overall Have Been Dropping But It’s Not All Good News, Report Shows

New Study Identifies Possible Cause of Polio-Like Disease, Acute Flaccid Myelitis

According to a story from Science Daily, a team of scientists from the Translational Genomics Research Institute (TGen) have identified the likely cause of a recent outbreak of an unusual…

Continue Reading New Study Identifies Possible Cause of Polio-Like Disease, Acute Flaccid Myelitis